SHAREHOLDER NOTICE:  Brodsky & Smith, LLC Announces an Investigation of Cascadian Therapeutics, Inc. – CASC


BALA CYNWYD, February 6, 2017 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Cascadian Therapeutics, Inc. (“Cascadian” or “the Company”) (Nadsaq- CASC-News) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Seattle Genetics, Inc. (“Seattle Genetics”).

Under the terms of the transaction, Cascadian shareholders will receive only $10.00 in cash for each share of Cascadian stock they own. The investigation concerns whether the Board of  Cascadian breached their fiduciary duties to shareholders and whether Seattle Genetics is underpaying for the Company. The transaction may undervalue the Company and would result in a loss for many Cascadian shareholders. For example, shares of Cascadian stock have traded at $22.44 per share and the Company’s most advanced drug in clinical trials, Tucatnib, has best in class potential for the treatment of various cancers.

If you own shares of Cascadian stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.